Showing of 0 - 10 from 144 results
Sun pharma - Total results - 144
Dec 20, 2016
Sun Pharma arm seeks USFDA nod for voluntary withdrawal of 28 ANDAs of RanbaxyThese older drug products belong to erstwhile Ranbaxy Laboratories and are not being marketed in the US since 2008
Nov 23, 2016
Sun Pharma to acquire Russian co JSC Biosintez for $60 millionThe Indian company will also assume Russian company's debt of $36 million
Nov 16, 2016
Sun Pharma arm Taro recalls 17,100 kits of dandruff care kits in USThe therapeutic 2-step Kamedis Bio-Herbal Dandruff Care System is used for treating itching and flaking associated with dandruff and seborrheic dermatitis
Nov 07, 2016
Hillary win may pose pricing challenges for pharma cos: ReportA Democrat sweep in US polls may pose even greater pricing challenges for the pharma industry and pave the way for tighter pricing regulations for both brand name and generic drugs, according to a report.
Oct 03, 2016
Sensex jumps 331 points, manufacturing PMI data fuel rallyThe benchmark Sensex rallied 331 points led by realty, auto, energy and industrials.
Sep 06, 2016
Sun Pharma inks distribution alliance with Mitsubishi Tanabe for 14 brandsThese 14 prescription brands acquired by the company earlier this year will be transferred from Novartis Pharma K.K. to Sun Pharma's subsidiary in Japan beginning October 2016
Aug 26, 2016
USFDA issues warning letter to ex-Sun Pharma US facilityThe Philadelphia plant is among the two facilities that Sun Pharma had sold to Frontida BioPharm in June this year, along with 15 products, for an undisclosed amount
Aug 08, 2016
CEO salaries soar; average nears Rs 20 cr, AM Naik draws highest at Rs 66.14 cr in private sectorThe analysis is based on the disclosures made by 20 out of the total 24 private sector companies on the Sensex, as the remaining four are yet to disclose their figures.
Jul 27, 2016
RPG Life Sciences enters deal to acquire Sun Pharma's 7 brandsThe move is in line with the company's strategy to focus on formulation business
Jul 18, 2016
Sun Pharma signs licensing deal with US arm for epilepsy drugThe US subsidiary is also eligible for certain additional milestone payments and defined royalties linked to any future sales of Elepsia XRTM